London
08048030295
+917498304432

Cabozantinib tablets for kidney, liver, and thyroid cancers. Targeted therapy inhibiting tumor growth pathways

LuciCaboz contains cabozantinib, a tyrosine kinase inhibitor used in treating advanced cancers such as renal cell carcinoma and hepatocellular carcinoma. It is widely prescribed in oncology for targeted cancer therapy.

Active Ingredient

Cabozantinib blocks multiple receptor tyrosine kinases involved in tumor growth and angiogenesis.

Uses of LuciCaboz

• Kidney cancer
• Liver cancer
• Thyroid cancer

How LuciCaboz Works

It inhibits multiple pathways including VEGF and MET, reducing tumor growth and blood supply to cancer cells.

How to Use LuciCaboz

• Take once daily as prescribed
• Swallow whole tablet
• Avoid food 2 hours before and after dose

Possible Side Effects

• Diarrhea
• Fatigue
• Hypertension
• Loss of appetite

Precautions

• Monitor blood pressure
• Liver function tests required
• Avoid grapefruit

Safety Information

Use under strict medical supervision with routine monitoring.

Storage

• Store at room temperature
• Keep away from moisture
• Keep out of reach of children

 2026-03-19T04:55:45

Other Pages

View all pages